glycine has been researched along with Adverse Drug Event in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The incidence of hemolysis-related ADRs, a potential cause of secondary acute renal impairment, was higher with glycine- and L-proline-stabilized IVIGs." | 4.89 | Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk. ( Dantal, J, 2013) |
| " The main outcome measures were the change in intraocular pressure (IOP) at week 4 and week 12 after the initiation of OMDI treatment, and frequency of adverse drug reactions." | 1.72 | Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan. ( Hori, K; Ishida, N; Miki, A; Miyamoto, E; Shii, D, 2022) |
| " It is concluded that no adverse effects related to the feeding of the NK603 maize cultivated with or without Roundup for up to 2 years were observed." | 1.51 | Lack of adverse effects in subchronic and chronic toxicity/carcinogenicity studies on the glyphosate-resistant genetically modified maize NK603 in Wistar Han RCC rats. ( Aláčová, R; Alison, C; Alison, R; Babincová, J; Baumgärtner, W; Becker, K; de Vriend, H; Goedhart, PW; Jaďuďová, S; Kebis, A; Kleter, G; Kok, EJ; Krivošíková, Z; Lempp, C; Líšková, A; Mikušová, ML; Nadal, A; Pla, M; Pöting, A; Racovita, M; Rollerová, E; Schiemann, J; Schmicke, M; Schrenk, D; Spök, A; Steinberg, P; Szabova, E; Takácsová, M; Tulinská, J; van der Voet, H; Wilhelm, R; Zeljenková, D, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 1 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Miki, A | 1 |
| Miyamoto, E | 1 |
| Ishida, N | 1 |
| Shii, D | 1 |
| Hori, K | 1 |
| Aihara, M | 1 |
| Lu, F | 1 |
| Kawata, H | 1 |
| Tanaka, Y | 1 |
| Yamamura, K | 1 |
| Odani-Kawabata, N | 1 |
| Shams, NK | 1 |
| Sharma, A | 1 |
| Pagidipati, NJ | 1 |
| Califf, RM | 1 |
| McGuire, DK | 1 |
| Green, JB | 1 |
| Demets, D | 1 |
| George, JT | 1 |
| Gerstein, HC | 1 |
| Hobbs, T | 1 |
| Holman, RR | 1 |
| Lawson, FC | 1 |
| Leiter, LA | 1 |
| Pfeffer, MA | 1 |
| Reusch, J | 1 |
| Riesmeyer, JS | 1 |
| Roe, MT | 1 |
| Rosenberg, Y | 1 |
| Temple, R | 1 |
| Wiviott, S | 1 |
| McMurray, J | 1 |
| Granger, C | 1 |
| Steinberg, P | 1 |
| van der Voet, H | 1 |
| Goedhart, PW | 1 |
| Kleter, G | 1 |
| Kok, EJ | 1 |
| Pla, M | 1 |
| Nadal, A | 1 |
| Zeljenková, D | 1 |
| Aláčová, R | 1 |
| Babincová, J | 1 |
| Rollerová, E | 1 |
| Jaďuďová, S | 1 |
| Kebis, A | 1 |
| Szabova, E | 1 |
| Tulinská, J | 1 |
| Líšková, A | 1 |
| Takácsová, M | 1 |
| Mikušová, ML | 1 |
| Krivošíková, Z | 1 |
| Spök, A | 1 |
| Racovita, M | 1 |
| de Vriend, H | 1 |
| Alison, R | 1 |
| Alison, C | 1 |
| Baumgärtner, W | 1 |
| Becker, K | 1 |
| Lempp, C | 1 |
| Schmicke, M | 1 |
| Schrenk, D | 1 |
| Pöting, A | 1 |
| Schiemann, J | 1 |
| Wilhelm, R | 1 |
| Dantal, J | 1 |
| Li, J | 1 |
| Kennedy, LJ | 1 |
| Shi, Y | 1 |
| Tao, S | 1 |
| Ye, XY | 1 |
| Chen, SY | 1 |
| Wang, Y | 1 |
| Hernández, AS | 1 |
| Wang, W | 1 |
| Devasthale, PV | 1 |
| Chen, S | 1 |
| Lai, Z | 1 |
| Zhang, H | 2 |
| Wu, S | 1 |
| Smirk, RA | 1 |
| Bolton, SA | 1 |
| Ryono, DE | 1 |
| Lim, NK | 1 |
| Chen, BC | 1 |
| Locke, KT | 1 |
| O'Malley, KM | 1 |
| Zhang, L | 2 |
| Srivastava, RA | 1 |
| Miao, B | 1 |
| Meyers, DS | 1 |
| Monshizadegan, H | 1 |
| Search, D | 1 |
| Grimm, D | 1 |
| Zhang, R | 1 |
| Harrity, T | 1 |
| Kunselman, LK | 1 |
| Cap, M | 1 |
| Kadiyala, P | 1 |
| Hosagrahara, V | 1 |
| Xu, C | 1 |
| Li, YX | 1 |
| Muckelbauer, JK | 1 |
| Chang, C | 1 |
| An, Y | 1 |
| Krystek, SR | 1 |
| Blanar, MA | 1 |
| Zahler, R | 1 |
| Mukherjee, R | 1 |
| Cheng, PT | 1 |
| Tino, JA | 1 |
| Mikalauskas, S | 1 |
| Mikalauskiene, L | 1 |
| Bruns, H | 1 |
| Nickkholgh, A | 1 |
| Hoffmann, K | 1 |
| Longerich, T | 1 |
| Strupas, K | 1 |
| Büchler, MW | 1 |
| Schemmer, P | 1 |
| Finkelstein, JB | 1 |
| Vest, MF | 1 |
1 review available for glycine and Adverse Drug Event
| Article | Year |
|---|---|
Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
Topics: Acute Kidney Injury; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Excipients; Glyci | 2013 |
1 trial available for glycine and Adverse Drug Event
| Article | Year |
|---|---|
Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Glycine; Healthy Volunteers; Humans; Intraoc | 2019 |
10 other studies available for glycine and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan.
Topics: Antihypertensive Agents; Drug-Related Side Effects and Adverse Reactions; Glaucoma; Glaucoma, Open-A | 2022 |
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; | 2020 |
Lack of adverse effects in subchronic and chronic toxicity/carcinogenicity studies on the glyphosate-resistant genetically modified maize NK603 in Wistar Han RCC rats.
Topics: Animal Feed; Animals; Carcinogenicity Tests; Drug Resistance; Drug-Related Side Effects and Adverse | 2019 |
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).
Topics: Animals; Cell Line; Cricetinae; Crystallography, X-Ray; Drug Discovery; Drug-Related Side Effects an | 2010 |
Dietary glycine protects from chemotherapy-induced hepatotoxicity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Chemical and Drug Induced Liver Injury; Colorectal Neo | 2011 |
Drug safety system needs overhaul, experts say.
Topics: Cardiovascular Diseases; Conflict of Interest; Drug Approval; Drug-Related Side Effects and Adverse | 2006 |
Drugs and the elderly mind.
Topics: Age Factors; Aged; Antidepressive Agents; Brain; Cognition Disorders; Drug-Related Side Effects and | 1972 |
The development of conjugation mechanisms and drug toxicity in the newborn.
Topics: Acetanilides; Acetylesterase; Aminobenzoates; Aminohippuric Acids; Bilirubin; Chloramphenicol; Drug- | 1965 |